On 25 September 2024, Head of Life Sciences, James Fry together with Stephanie Caird and Isabel Teare, along with regulatory consultants Alisdair Falconer at DLRC, and Timothy Bubb at iMed, recorded their collective expert views on the current regulatory trends for both medicines and medical devices and how they see regulation developing over the short and mid-term. They will also discuss what businesses in the sector need to watch out for.